Chrogene Aarogyam Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 79.21%
- Ebitda -351.97%
- Net Worth 420.20%
- Total Assets 116.15%
About Chrogene Aarogyam Biotech
Chrogene Aarogyam Biotech Private Limited (CABPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 October 2017 (Seven years and four months 12 days old ). Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tamilmani Shanmugam, Poongothai Ramaswamy, and Ramaswamy Ayyapalayam serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999TG2017PTC120066
- Company No.
120066
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2017
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Chrogene Aarogyam Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tamilmani Shanmugam  | Additional Director | 11-Mar-2024 | Current |
| Poongothai Ramaswamy | Director | 13-Oct-2017 | Current |
| Ramaswamy Ayyapalayam | Director | 13-Oct-2017 | Current |
Financial Performance of Chrogene Aarogyam Biotech.
Chrogene Aarogyam Biotech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 79.21% increase in profit. The company's net worth Soared by an impressive increase of 420.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chrogene Aarogyam Biotech?
In 2020, Chrogene Aarogyam Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanhoc Hospitality LlpTamilmani Shanmugam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chrogene Aarogyam Biotech?
Unlock and access historical data on people associated with Chrogene Aarogyam Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chrogene Aarogyam Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chrogene Aarogyam Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.